Skip to content
Home/Companies/Biotech/Evolva

Evolva

Biotech·Switzerland·Exited 2009·Held 4yr
Entry
2005
Hold
4yr
Exit
2009

Who owns Evolva?

Evolva was owned by Sunstone Life Science Ventures through Sunstone Life Science Ventures III (2007 vintage) from 2005 to 2009, exited via IPO.

Hand-verified · updated 2026-08-18

Sunstone Life Science Ventures
Investor
Sunstone Life Science Ventures
Sunstone Life Science Ventures III · 2007 · VC

Key facts

HQSwitzerland
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2009

More from Sunstone Life Science Ventures III

Other portfolio companies in the same fund.

MinervaX
MinervaX
Active
BiotechDenmark· 2014
Cantargia
Exited 2015
BiotechSweden· 2013
Opsona Therapeutics
Exited 2019
BiotechIreland· 2013
Follicum
Exited 2014
BiotechSweden· 2012
to
Galecto
Exited 2020
BiotechDenmark· 2012
Orphazyme
Orphazyme
Exited 2017
BiotechDenmark· 2011

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track Evolva

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Evolva?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Evolva.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue